Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis.
Compston JE, Audran M, Avouac B, Bouvenot G, Devogelaer J, Eastell R, Fabris F, Gennari C, Jones EA, Kaufman JM, Lemmel E, Mazzuoli G, Reid DM, Ringe JD, Vanhaelst L, Ziegler R, Reginster JY. Compston JE, et al. Among authors: vanhaelst l. Calcif Tissue Int. 1996 Nov;59(5):323-7. doi: 10.1007/s002239900134. Calcif Tissue Int. 1996. PMID: 8849396 No abstract available.
Do estrogens effectively prevent osteoporosis-related fractures? The Group for the Respect of Ethics and Excellence in Science.
Reginster JY, Bruyere O, Audran M, Avouac B, Body JJ, Bouvenot G, Brandi ML, Gennari C, Kaufman JM, Lemmel EM, Vanhaelst L, Weryha G, Devogelaer JP. Reginster JY, et al. Among authors: vanhaelst l. Calcif Tissue Int. 2000 Sep;67(3):191-4. doi: 10.1007/s002230001135. Calcif Tissue Int. 2000. PMID: 10954771 Free article. Review. No abstract available.
Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science.
Abadie EC, Devogealer JP, Ringe JD, Ethgen DJ, Bouvenot GM, Kreutz G, Laslop A, Orloff JJ, Vanderauwera PM, Delmas PD, Dere WH, Branco J, Altman RD, Avouac BP, Menkes CJ, Vanhaelst L, Mitlak BH, Tsouderos Y, Reginster JY. Abadie EC, et al. Among authors: vanhaelst l. Semin Arthritis Rheum. 2005 Aug;35(1):1-4. doi: 10.1016/j.semarthrit.2005.03.006. Semin Arthritis Rheum. 2005. PMID: 16084217 Review.
[Postmenopausal osteoporosis in women].
Reginster JY, Devogelaer JP, Kaufman JM, Appelboom T, Vanhaelst L. Reginster JY, et al. Among authors: vanhaelst l. Rev Med Liege. 1999 Apr;54(4):335-40. Rev Med Liege. 1999. PMID: 10389480 Free article. French.
Background for studies on the treatment of male osteoporosis: state of the art.
Kaufman JM, Johnell O, Abadie E, Adami S, Audran M, Avouac B, Sedrine WB, Calvo G, Devogelaer JP, Fuchs V, Kreutz G, Nilsson P, Pols H, Ringe J, Van Haelst L, Reginster JY. Kaufman JM, et al. Ann Rheum Dis. 2000 Oct;59(10):765-72. doi: 10.1136/ard.59.10.765. Ann Rheum Dis. 2000. PMID: 11005775 Free PMC article. Review.
Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis.
Altman RD, Abadie E, Avouac B, Bouvenot G, Branco J, Bruyere O, Calvo G, Devogelaer JP, Dreiser RL, Herrero-Beaumont G, Kahan A, Kreutz G, Laslop A, Lemmel EM, Menkes CJ, Pavelka K, Van De Putte L, Vanhaelst L, Reginster JY; Group for Respect of Excellence and Ethics in Science (GREES). Altman RD, et al. Among authors: vanhaelst l. Osteoarthritis Cartilage. 2005 Jan;13(1):13-9. doi: 10.1016/j.joca.2004.10.012. Osteoarthritis Cartilage. 2005. PMID: 15639632 Free article. Review.
Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.
Abadie E, Ethgen D, Avouac B, Bouvenot G, Branco J, Bruyere O, Calvo G, Devogelaer JP, Dreiser RL, Herrero-Beaumont G, Kahan A, Kreutz G, Laslop A, Lemmel EM, Nuki G, Van De Putte L, Vanhaelst L, Reginster JY; Group for the Respect of Excellence and Ethics in Science. Abadie E, et al. Among authors: vanhaelst l. Osteoarthritis Cartilage. 2004 Apr;12(4):263-8. doi: 10.1016/j.joca.2004.01.006. Osteoarthritis Cartilage. 2004. PMID: 15023377 Free article. Review.
Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules. Department of Urogynaecology, King's College Hospital, London.
Stevenson JC, Gaspard U, Avouac B, Bricaire C, Cardozo L, Collins P, Devogelaer JP, Dören M, Gennari C, Kaufman JM, Kuttenn F, Ringe JD, Scarafiotti C, Vanhaelst L, Zichella L, Ziegler R, Reginster JY. Stevenson JC, et al. Among authors: vanhaelst l. Climacteric. 1998 Mar;1(1):12-7. doi: 10.3109/13697139809080676. Climacteric. 1998. PMID: 11913406 Review. No abstract available.
154 results